Franz Humer | |
---|---|
Born | Franz Bernhard Humer 1 July 1946 Salzburg |
Nationality | Swiss-Austrian |
Occupation | Businessman |
Years active | 1967–present |
Title | Former chairman of Roche and Diageo plc |
Board member of | Roche, Diageo, Citigroup, International Centre for Missing & Exploited Children (ICMEC; Chairman) |
Franz Bernhard Humer (born 1 July 1946, in Salzburg, Austria) [1] is a Swiss-Austrian businessman, and the former chairman of Diageo, [2] and of Roche.
Humer studied law at the University of Innsbruck and later obtained a doctorate in law. He also earned a master's degree in business from INSEAD in Fontainebleau. [1] [3]
Between 1973 and 1995, Humer worked for pharmaceutical companies Schering-Plough and Glaxo in various countries. [1] [4]
He became a member of the board of directors and head of the pharmaceuticals division of the Swiss pharmaceutical company Roche in 1995. From 1996 until 1998 he was COO of Roche, then CEO until 2008, when Severin Schwan took over. Additionally, he was chairman from 2001 to 2014. [4] [5]
Humer was chairman of Reed Elsevier from July 2008 to September 2010, when he was succeeded by Anthony Habgood. [6]
He was chairman of Diageo, a British multinational alcoholic beverages company, until January 2017, when he was succeeded by Javier Ferrán. [7] [8]
Humer is married and lives in Erlenbach, Switzerland. [9] He obtained Swiss citizenship in 1989. [1]
Humer was chairman of the International Centre for Missing & Exploited Children, a global non-profit organization that combats child sexual exploitation, child pornography, and child abduction. [10] [11] Humer was chairman at the INSEAD school of business from 2008 to 2014. [12]
Ajay Gopikisan Piramal is an Indian billionaire businessman, and the chairman of the Piramal Group, a conglomerate with interests in pharmaceutical, financial services, real estate, healthcare analytics and glass packaging. As of July 2024, his net worth is estimated at US$2.8 billion.
Ursula M. Burns is an American businesswoman. Burns is known for her tenure as the CEO of Xerox from 2009 to 2016. In this role, Burns was the first black woman to lead a Fortune 500 company. She is also the first woman to follow another as the head of a Fortune 500 company. Burns remained the chairman at Xerox from 2010 to 2017.
Daniel Lucius Vasella is a Swiss medical doctor, author, and executive who was CEO and chairman of the Swiss pharmaceutical company Novartis AG, the world's fifth largest drug company. During his tenure Novartis shares fell 10%, compared to the industry average. In February 2013 Vasella was awarded close to $78 million in a "golden handshake"
Axel Alfred Weber is a German economist, professor, and banker. He is currently a board member and chairman of Swiss investment bank and financial services company, UBS Group AG, and has announced his resignation effective 7 April 2022.
Roland Berger is a German entrepreneur, consultant and philanthropist.
Evan Mervyn Davies, Baron Davies of Abersoch, is a British former banker and was a Labour government minister until May 2010, as Minister of State for Trade, Investment and Small Business. Davies remains a UK government Trade Envoy for Sri Lanka.
Lion Capital LLP is a British private equity firm specialising in investments in the consumer sector. Previous and current consumer brands owned by Lion have included Weetabix, Jimmy Choo, Wagamama, Kettle Foods and AllSaints.
Christoph Franz is a German engineer and manager who served as chief executive officer of Lufthansa from 2011 until 2014.
Severin Anton Schwan is an Austrian business executive. He is the current chairman of the board and former CEO (2008–2023) of the Roche Group.
Branco Weiss was a Swiss entrepreneur and patron.
Ralf Dieter Speth is a German automotive executive and a director of Indian company Tata Sons since 2016. From 2010 to 2020, he was the chief executive officer of Jaguar Land Rover. He has also had roles with BMW, Linde and Ford's Premier Automotive Group. Since 2022, Speth is the chairman of Indian Automaker TVS Motor Company.
Francisco Javier Ferrán Larraz is a Spanish businessman. He was president and chief executive officer (CEO) of Bacardi from 2003 to 2004.
David Ebsworth is non-executive chairman at Verona Pharma Plc. His career spans over 35 years in the global pharmaceutical industry, during which he was Global Head of Pharmaceuticals at Bayer AG and CEO of a number of companies, including ViforPharma and Galenica. He is also an advisor to a variety of CEOs at public and private organisations.
Etienne Jean Jornod is a Swiss entrepreneur and manager. He was Chairman of the Board of Directors of the pharmaceutical and logistics group Galenica and the NZZ Mediengruppe.
Hagen Pfundner is a German pharmacist and industrial manager. He is a member of the Board of the Bundesverband der Deutschen Industrie (BDI), the Foundation of German Industries) and the Verband Forschender Arzneimittelhersteller, as well as being an honorary professor of Freiburg University and chairman of the University Council of the DHBW Lörrach.
Frank Heinricht is a German physicist with a doctorate in engineering He has been Chairman of the Board of Management of Schott AG in Mainz since June 1, 2013.
André Hoffmann is a Swiss billionaire businessman, environmentalist and philanthropist.
Fritz Gerber was a Swiss business executive. He was the Chief Executive Officer of Hoffmann-La Roche from 1978 to 1998. From 1977 to 1991, he was also the CEO of Zurich Insurance Group. Under his management, Roche expanded to become a significant player in biotechnology and diagnostics.
Thomas Schinecker is an Austrian-German pharmaceutical executive and the chief executive officer of the Roche Group since March 2023. He succeeded Severin Schwan, who was elected chairman of the board of directors of the Roche Group.